Three EU hospitals tap into HIMSS to assess health IT progress

Three European hospitals have recently reached Stage 6 on the EMR Adoption Model (EMRAM) scale, the Healthcare Information and Management Systems Society’s (HIMSS) rating system to track the progress of healthcare facilities’ efforts to implement new health IT programs.

According to HIMSS Analytics Europe CEO Uwe Buddrus, “For a hospital to achieve Stage 6 on the EMRAM scale means that it has successfully tackled some key challenges in the adoption of EMRs.”

Italy’s Azienda ULSS 18 Rovigo, Spain’s Hospital Clinic I Provincial de Barcelona and Switzerland’s Inselspital, Bern University Hospital each fulfilled the requirements of a Stage 6 rating, which is awarded when a hospital demonstrates that it has fulfilled all requirements of previous stages, developed a hospital-wide closed-loop medication administration environment and implemented clinical decision support system in at least one inpatient care service area.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.